47
Views
5
CrossRef citations to date
0
Altmetric
Commentary

Potential renovascular hypertension, space missions, and the role of magnesium

Pages 51-57 | Published online: 19 Nov 2009

References

  • RoweWJThe Apollo 15 space syndromeCirculation1998971191209443446
  • WatenpaughDEBuckeyJCLaneLDEffects of spaceflight on human calf hemodynamicsJ Appl Physiol2001901552155811247959
  • RoweWJInterplanetary travel and permanent injury to normal heartActa Astronaut19974071971072211543600
  • RoweWJMoon dust may simulate vascular hazards of urban pollutionJBIS200760133136
  • HigashiYSasakiSNakagawaKMatsuuraHOshimaTChayamaKEndothelial function and oxidative stress in renovascular hypertensionN Engl J Med20023461954196212075056
  • LinKFChaoJChaoLHuman atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive ratsHypertension199526Part 18478537490138
  • OhiSDeveloping protocols for recombinant adeno-associated virus-mediated gene therapy in spaceJ Gravit Physiol200076768
  • AmidonGLDeBrincatGANajibNEffects of gravity on gastric emptying, intestinal transit, and drug absorptionJ Clin Pharmacol1991319689731761729
  • DuJBayuseTMShahVPutchaLStability of pharmaceuticals during space flight [abstract]AAPS Pharm Sci2002T3153
  • GraebeASchuckELLensingPPutchaLDerendorfHPhysiolgical, pharmacokinetic, and pharmacodynamic changes in spaceJ Clin Pharmacol20044483785315286087
  • WadeCEMorey-HoltonEAlteration of renal function of rats following spaceflightAm J Physiol1998275R1058R10659756534
  • Fritsch-YelleJMCharlesJBJonesMMWoodMLMicrogravity decreases heart rate and arterial pressure in humansJ Appl Physiol1996809109148964756
  • ShiraishiMKamoTKamegaiMPeriodic structures and diurnal variation in blood pressure and heart rate in relation to microgravity on space station MIRBiomed Pharmacother200458S31S3415754836
  • MatsukawaTManoTAtrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humansAm J Physiol19962712 Pt 2R464R4718770149
  • CostaDMGonzalez BoscLVMajowiczMPVidalNABalaszczukAMArranzCTAtrial natriuretipeptide modifies arterial blood pressure through nitric oxide pathway in ratsHypertension2000351119112310818074
  • WongNLMHuDCKWongEFCEffect of dietary magnesium on atrial natriuretic peptide releaseAm J Physiol19912615 Pt 2H1353H3571835306
  • Leach HuntoonCSGrigorievAINatochinYVAmerican Astronaut SocietyFluid and Electrolyte Regulation in Spaceflight. (Science and Technology Series 94)San Diego, CAUnivelt1998
  • AtkovOYBednenkoVSHypokinesia and Weightlessness: Clinical and physiologic aspectsMadison, WIInternational Universities Press1992167
  • NeuhoferWPittrowDRole of endothelin and endothelin receptor antagonists in renal diseaseEur J Clin Invest200636788816919017
  • LiaoTDYangXPLiuYHRole of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertensionHypertension20085225626318541733
  • DhaunNGoddardJWebbDJThe endothelin system and its antagonism in chronic kidney diseaseJ Am Soc Nephrol20061794395516540557
  • PedrinelliRGiampietroOCarmassiFMicroalbuminuria and endothelial dysfunction in essential hypertensionLancet199434414187912295
  • Mena-MartínFJMartín-EscuderoJCSimal-BlancoFCarretero-AresJLArzúa-MouronteDCastrodeza SanzJJHortega Study Investigators. Influence of sympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretionJ Clin Hypertens (Greenwich)2006861962416957423
  • FutrakulNSridamaVFutrakulPMicroalbuminuria – A biomarker of renal microvascular diseaseRen Fail20093114014319212911
  • WangTJEvansJCMeigsJBLow-grade albuminuria and the risks of hypertension and blood pressure progressionCirculation20051111370137615738353
  • RadomskiMWPalmerRMJMoncadaSEndogenous nitric oxide inhibits human platelet adhesion to vascular endotheliumLancet198728567105710582889967
  • RoweWJThe case for a subcutaneous magnesium product and delivery device for space missionsJ Am Coll Nutr200423525S528S15466957
  • HaraAWadaTFuruichiKBlockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritisKidney Int2006691986199516641924
  • MasudaYShimizuAMoriTVascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritisAm J Pathol200115959960811485918
  • DavidsonMBHixJKVidtDGBrotmanDJAssociation of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rateArch Intern Med200616684685216636209
  • PhilpottDEPopovaIAKatoKStevensonJMiquelJSappWMorphological and biochemical examination of Cosmos 1887 rat heart tissue: Part I – UltrastructureFASEB J1990473782295379
  • SteinTPSpace flight and oxidative stressNutrition20021886787112361781
  • GarciaLADejongSCMartinSMSmithRSBuettnerGRKerberREMagnesium reduces free radicals in an in vivo coronary occlusion reperfusion modelJ Am Coll Cardiol1998325365399708488
  • GracianoMLCavaglieri RdeCDellêHIntrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesisJ Am Soc Nephrol2004151805181515213268
  • CampbellRCThe renin-angiotensin system: a 21st century perspectiveJ Am Soc Nephrol2004151963196415213288
  • GrassiGAssessment of sympathetic cardiovascular drive in human hypertensionHypertension20095469070619720958
  • ChristensenNJDrummerCNorskPRenal and sympathoadrenal responses in spaceAm J Kidney Dis20013867968311532706
  • BrennerBMBallermanBJGunningMEZeidelMLDiverse biological actions of atrial natriuretic peptidePhysiol Rev1990706656992141944
  • SeeligMCardiovascular consequences of magnesium deficiency and loss: pathogenesis prevalence and manifestations-magnesium and chloride loss in refractory potassium repletionAm J Cardiol1989634G21G
  • SontiaBMontezanoACIParaviciniTTabetFTouyzRMDown-regulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesiumHypertension20085191592118268139
  • RemuzziGCattaneoDPericoNThe aggravating mechanisms of aldosterone on kidney fibrosisJ Am Soc Nephrol2008191459146218550649
  • ClarkBAElahiDEpsteinFHThe influence of gender, age, and the menstrual cycle on plasma natriuretic peptideJ Clin Endocrin Metab199070349352
  • RosslerANoskovVLaszloZPolyakowVVHinghoffer-SzalkayHGPermanent depression of plasma cGMP during long-term space flightPhysiol Res200150839011300230
  • Malamitsi-PuchnerATziotisJTsonouAProtonotariouESarandakouACreatsasGChanges in serum levels of vascular endothelial growth factor in males and females throughout lifeJ Soc Gynecol Investig20007309312
  • VaziriNDRodriguez-IturbeBMechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertensionNat Clin Pract Nephrol2006258259317003837
  • RoweWJExtraordinary hypertension after a lunar missionAm J Med2009122e119854309
  • DzieciuchowiczLChecinskiPKraussHHeparin reduces oxidative stress in the postoperative periodMed Sci Monit20028CR657CR66012218949
  • MaierJAMMalpuech-BrugèreCZimowskaWRayssiguierYMazurALow magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosisBiochim Biophys Acta20041689132115158909
  • WeglickiWBPhillipsTMFreedmanAMCassidyMMDickensBFMagnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelinMol Cell Biochem19921101691731584207
  • LinKFChaoLChaoJProlonged reduction of high blood pressure with human nitric oxide synthase gene deliveryHypertension199730Part 13073139314409
  • SchillingerKJTsaiSYTaffetGERegulatable atrial natriuretic peptide gene therapy for hypertensionProc Natl Acad Sci U S A2005102137891379416162668
  • McCarthyHOCoulterJARobsonTHirstDGGene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditionsJ Pharm Pharmacol200860999101718644193
  • KohnDBCandottiFGene therapy fulfilling its promiseN Engl J Med200936051852119179320